Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis

Psoriasis is a common inflammatory skin disease characterized by thickened scaly red plaques. Previously we have performed a genome-wide association study (GWAS) on psoriasis with 1,359 cases and 1,400 controls, which were genotyped for 447,249 SNPs. The most significant finding was for SNP rs12191877, which is in tight linkage disequilibrium with HLA-Cw*0602, the consensus risk allele for psoriasis. However, it is not known whether there are other psoriasis loci within the MHC in addition to HLA-C. In the present study, we searched for additional susceptibility loci within the human leukocyte antigen (HLA) region through in-depth analyses of the GWAS data; then, we followed up our findings in an independent Han Chinese 1,139 psoriasis cases and 1,132 controls. Using the phased CEPH dataset as a reference, we imputed the HLA-Cw*0602 in all samples with high accuracy. The association of the imputed HLA-Cw*0602 dosage with disease was much stronger than that of the most significantly associated SNP, rs12191877. Adjusting for HLA-Cw*0602, there were two remaining association signals: one demonstrated by rs2073048 (p = 2×10−6, OR = 0.66), located within c6orf10, a potential downstream effecter of TNF-alpha, and one indicated by rs13437088 (p = 9×10−6, OR = 1.3), located 30 kb centromeric of HLA-B and 16 kb telomeric of MICA. When HLA-Cw*0602, rs2073048, and rs13437088 were all included in a logistic regression model, each of them was significantly associated with disease (p = 3×10−47, 6×10−8, and 3×10−7, respectively). Both putative loci were also significantly associated in the Han Chinese samples after controlling for the imputed HLA-Cw*0602. A detailed analysis of HLA-B in both populations demonstrated that HLA-B*57 was associated with an increased risk of psoriasis and HLA-B*40 a decreased risk, independently of HLA-Cw*0602 and the C6orf10 locus, suggesting the potential pathogenic involvement of HLA-B. These results demonstrate that there are at least two additional loci within the MHC conferring risk of psoriasis.

[1]  Wei Huang,et al.  Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 , 2009, Nature Genetics.

[2]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[3]  J. Traherne,et al.  Review Article doi: 10.1111/j.1744-313X.2008.00765.x Blackwell , 2022 .

[4]  Cisca Wijmenga,et al.  Effective Detection of Human Leukocyte Antigen Risk Alleles in Celiac Disease Using Tag Single Nucleotide Polymorphisms , 2008, PloS one.

[5]  Yung-Ting Chang,et al.  Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. , 2008, The Journal of rheumatology.

[6]  Sen Yang,et al.  Fine Mapping of the Psoriasis Susceptibility Locus PSORS1 Supports HLA-C as the Susceptibility Gene in the Han Chinese Population , 2008, PLoS genetics.

[7]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[8]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[9]  T. Gao,et al.  TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. , 2007, The Journal of investigative dermatology.

[10]  C. Griffiths,et al.  Pathogenesis and clinical features of psoriasis , 2007, The Lancet.

[11]  B. Nedoszytko,et al.  Associations of promoter region polymorphisms in the tumour necrosis factor‐α gene and early‐onset psoriasis vulgaris in a northern Polish population , 2007, The British journal of dermatology.

[12]  M. Gilthorpe,et al.  Haplotype uncertainty in association studies , 2007, Genetic epidemiology.

[13]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[14]  Steven J. Schrodi,et al.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.

[15]  E. Donadi,et al.  Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. , 2006, European journal of dermatology : EJD.

[16]  Pardis C Sabeti,et al.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.

[17]  R. Kaslow,et al.  Conserved extended haplotypes of the major histocompatibility complex: further characterization , 2006, Genes and Immunity.

[18]  Stefan Jenisch,et al.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.

[19]  C. López-Larrea,et al.  The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population. , 2005, The Journal of investigative dermatology.

[20]  T. M. Hsu,et al.  Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR , 2005, Human Genetics.

[21]  M. Blumenberg,et al.  Pathway-specific Profiling Identifies the NF-κB-dependent Tumor Necrosis Factor α-regulated Genes in Epidermal Keratinocytes* , 2005, Journal of Biological Chemistry.

[22]  Stephan Beck,et al.  A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. , 2005, American journal of human genetics.

[23]  M. Iles,et al.  Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatibility complex haplotype for psoriasis in a Caucasian population. , 2005, The Journal of investigative dermatology.

[24]  M. Stephens,et al.  Accounting for Decay of Linkage Disequilibrium in Haplotype Inference and Missing-data Imputation , 2022 .

[25]  James T. Elder,et al.  Genetic epidemiology of psoriasis and psoriatic arthritis , 2005, Annals of the rheumatic diseases.

[26]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[27]  J. Gudjonsson,et al.  Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin‐homing CD8+ T cells , 2004, Clinical and experimental immunology.

[28]  R. Trembath,et al.  An update on the genetics of psoriasis. , 2004, Dermatologic clinics.

[29]  Xuejun Zhang,et al.  HLA‐DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Chinese Han , 2004, International journal of dermatology.

[30]  Oguz Fatma,et al.  HLA-DRB1 association in Turkish psoriasis vulgaris patients. , 2003, Swiss medical weekly.

[31]  K. P. O'Brien,et al.  Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population , 2003, Experimental dermatology.

[32]  J. Gulcher,et al.  Psoriasis patients who are homozygous for the HLA‐Cw*0602 allele have a 2·5‐fold increased risk of developing psoriasis compared with Cw6 heterozygotes , 2003, The British journal of dermatology.

[33]  J. Mužík,et al.  Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis , 2002, Archives of Dermatological Research.

[34]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[35]  C. López-Larrea,et al.  The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. , 2000, The Journal of investigative dermatology.

[36]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[37]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[38]  H. Inoko,et al.  Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. , 1999, Human molecular genetics.

[39]  A. Little,et al.  Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. , 1999, The Journal of investigative dermatology.

[40]  N. Zhai,et al.  The relationship of HLA-DRB1 * 0701 allele with the psoriasis vulgaris. , 1999, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[41]  James T. Elder,et al.  Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes. , 1999, Tissue antigens.

[42]  S. Jee,et al.  HLA‐DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population , 1998, The British journal of dermatology.

[43]  P. Stastny,et al.  Role of HLA-B and C alleles in development of psoriasis in patients from North India. , 1998, Tissue antigens.

[44]  W. Sterry,et al.  Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. , 1996, The Journal of investigative dermatology.

[45]  V. Morhenn,et al.  HLA C and D antigens associated with psoriasis , 1978, The British journal of dermatology.

[46]  Joachim Reischl,et al.  Increased expression of Wnt5a in psoriatic plaques. , 2007, The Journal of investigative dermatology.

[47]  M. Blumenberg,et al.  Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. , 2005, The Journal of biological chemistry.

[48]  C. Carcassi,et al.  Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). , 2005, American journal of human genetics.